Ionis Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $129.6M | $84.7M | $128.8M | $143.0M | $160.0M | $124.5M | $65.5M | $70.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | $10.0M | — | — | — | — | — | — | — |
| Total Current Assets | $1.17B | $797.9M | $837.0M | $836.6M | $735.5M | $423.4M | $360.1M | $483.1M |
| Property, Plant & Equipment | $121.9M | $92.8M | $90.2M | $89.0M | $86.2M | $91.1M | $96.6M | $35.7M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $22.0M | $20.4M | — | — | — | — | — | — |
| Total Assets | $1.32B | $912.5M | $947.9M | $955.8M | $847.2M | $545.7M | $484.9M | $550.5M |
| Liabilities | ||||||||
| Accounts Payable | $24.9M | $21.1M | $28.4M | $18.0M | $11.0M | $10.2M | $8.3M | $6.5M |
| Total Current Liabilities | $243.6M | $133.8M | $148.9M | $115.3M | $97.8M | $74.3M | $76.1M | $105.9M |
| Long-Term Debt | — | — | — | — | — | — | $145.6M | $148.8M |
| Total Liabilities | $957.5M | $812.9M | $747.1M | $698.0M | $468.8M | $362.9M | $313.5M | $305.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.24B | $-1.18B | $-1.09B | $-1.01B | $-967.6M | $-907.0M | $-841.5M | $-756.7M |
| Total Stockholders' Equity | $281.0M | $99.6M | $200.8M | $257.8M | $378.4M | $182.8M | $171.4M | $244.5M |